Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emyr Bakker
P53 Modeling as a Route to Mesothelioma Patients Stratification and Novel Therapeutic Identification
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma
PLoS ONE
Multidisciplinary
Inhibition of the Spindle Assembly Checkpoint Kinase MPS-1 as a Novel Therapeutic Strategy in Malignant Mesothelioma
Oncogene
Cancer Research
Genetics
Molecular Biology
Quinols as Novel Therapeutic Agents. 8. Applications of the Sonogashira Route to Thioredoxin-Inhibitory Indolyl-Substituted Quinols
Arkivoc
Organic Chemistry
Aurora-A Overexpression Reveals Tetraploidization as a Major Route to Centrosome Amplification in P53-/- Cells
EMBO Journal
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
P1.02-052 Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Identification of Novel Blood Biomarker Panels to Detect Ischemic Stroke in Patients and Their Responsiveness to Therapeutic Intervention
Brain Research
Neuroscience
Neurology
Developmental Biology
Molecular Biology
GPR35 as a Novel Therapeutic Target
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes
P2.06-20 Bacteria as Novel Anti-Mesothelioma Agents.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Identification of TRIML2, a Novel P53 Target, That Enhances P53 SUMOylation and Regulates the Transactivation of Proapoptotic Genes
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology